[21] This was a smaller study that enrolled 74 patients 65 years and older with NYHA class II or III heart failure (defined by the Framingham criteria) and an ejection fraction ≥40%. Background ...

Candesartan (CHARM-P) 3023 EF >40%; mean age: 67; NYHA class II–IV ... Heart failure normal ejection fraction (HFNEF) is growing at an alarming rate and has a complex pathophysiology.

symptoms of NYHA class 3–4 heart failure, and low ejection fraction associated with mild left ventricular dilation, among other signs of heart dysfunction. Transmission electron micrographs of ...

Heart failure outcomes in patients with type 2 diabetes receiving once-weekly exenatide are affected by left ventricular ejection fraction.

In this randomized controlled trial of patients with heart failure and mildly decreased or preserved ejection fraction, ...

The main outcome measures are cardiovascular death and the change from baseline in NYHA classification, left ventricular ejection fraction (LVEF), peak oxygen (VO2), and six-minute walk test ...

CHICAGO, IL—A novel noninvasive intracardiac pressure monitoring device powered by artificial intelligence (AI) could be a ...

Factors portending the greatest risk for cardiovascular death in control patients were inflammation (baseline plasma high-sensitivity C-reactive protein =2 mg/L; p=0.003) and ischemic HFrEF etiology ...

Compared with placebo, sodium zirconium cyclosilicate was associated with less need to lower or discontinue spironolactone.

Treatment with the potassium binder sodium zirconium cyclosilicate (SZC; Lokelma) stabilized potassium levels among patients ...